New Results
A pharmacophore model for SARS-CoV-2 3CLpro small molecule inhibitors and in vitro experimental validation of computationally screened inhibitors
View ORCID ProfileEnrico Glaab, View ORCID ProfileGanesh Babu Manoharan, View ORCID ProfileDaniel Abankwa
doi: https://doi.org/10.1101/2021.03.02.433618
Enrico Glaab
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 7 avenue des Hauts Fourneaux, L-4362 Esch-sur-Alzette, Luxembourg
Ganesh Babu Manoharan
2Department of Life Sciences and Medicine, University of Luxembourg, 7 avenue des Hauts Fourneaux, L-4362 Esch-sur-Alzette, Luxembourg
Daniel Abankwa
2Department of Life Sciences and Medicine, University of Luxembourg, 7 avenue des Hauts Fourneaux, L-4362 Esch-sur-Alzette, Luxembourg
Article usage
Posted March 03, 2021.
A pharmacophore model for SARS-CoV-2 3CLpro small molecule inhibitors and in vitro experimental validation of computationally screened inhibitors
Enrico Glaab, Ganesh Babu Manoharan, Daniel Abankwa
bioRxiv 2021.03.02.433618; doi: https://doi.org/10.1101/2021.03.02.433618
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29194)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18305)
- Genetics (12245)
- Genomics (16801)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60962)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)